Risius Tim, Lewalter Thorsten, Lüderitz Berndt, Schwab Jörg O, Spitzer Stefan, Schmitt Claus, Vester Ernst, Rostock Thomas, Meinertz Thomas, Willems Stephan
Department of Cardiology, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
Europace. 2006 Mar;8(3):178-81. doi: 10.1093/europace/euj013. Epub 2006 Jan 5.
Paroxysmal atrial fibrillation (PAF) is predominantly triggered by focal ectopies located within the pulmonary veins (PV). The BITMAP Study (Breakthrough and Isolation Trial: Mapping and Ablation of Pulmonary Veins) investigated prospectively the safety and efficacy of a catheter design with circumferential mapping and ablation electrodes. We report the phenomenon of ST-segment-elevation during catheter placement in the left atrium (LA) and superior PVs in this multi-centre study.
Forty-three patients (57+/-10 years) with PAF were included in this study. Radiofrequency catheter (RFC) ablation supported by the 4F REVELATION Helix microcatheter (Cardima Inc., Freemont, CA, USA) with eight distal-coiled microelectrodes for bipolar mapping and ablation. RFC was applied at the ostial region of PV (30 W, 45-50 degrees C) with a maximum of four RFC applications per electrode. In four of the 43 patients from three centres, we recorded the occurrence of ST-segment-elevation greater than 0.2 mV and accompanying left thoracic discomfort. The ECG changes and the symptoms started abruptly and lasted for 4.2+/-2.2 min. Pericardial effusion could instantaneously be excluded by echocardiography in all cases. Coronary angiograms were performed in three patients with the longest episodes; no thrombotic material or air emboli were present. The symptoms and the ECG changes resolved completely in all patients.
The phenomenon of ST-segment-elevation during LA- and PV-mapping in patients with PAF may be a common occurrence. In this prospective multi-centre trial, we demonstrated the reversibility of this phenomenon; no cardiovascular or cerebral damage was reported during both the procedure and the follow-up. Although the mechanism is still unclear, vasospasm may contribute to this phenomenon because of autonomic dysregulation.
阵发性心房颤动(PAF)主要由肺静脉(PV)内的局灶性异位搏动触发。BITMAP研究(突破性隔离试验:肺静脉标测与消融)前瞻性地研究了一种带有环形标测和消融电极的导管设计的安全性和有效性。在这项多中心研究中,我们报告了在左心房(LA)和上肺静脉放置导管期间ST段抬高的现象。
本研究纳入了43例PAF患者(年龄57±10岁)。采用美国加利福尼亚州弗里蒙特市Cardima公司生产的4F REVELATION Helix微导管支持的射频导管(RFC)进行消融,该微导管带有8个远端螺旋微电极用于双极标测和消融。在PV开口区域施加RFC(30W,45 - 50℃),每个电极最多进行4次RFC应用。在来自三个中心的43例患者中的4例中,我们记录到ST段抬高大于0.2mV并伴有左胸不适。心电图变化和症状突然出现,持续4.2±2.2分钟。所有病例均通过超声心动图即时排除心包积液。对发作时间最长的3例患者进行了冠状动脉造影;未发现血栓物质或空气栓子。所有患者的症状和心电图变化均完全缓解。
PAF患者在LA和PV标测期间出现ST段抬高现象可能较为常见。在这项前瞻性多中心试验中,我们证明了这种现象的可逆性;在手术过程和随访期间均未报告心血管或脑损伤。尽管机制尚不清楚,但由于自主神经调节异常,血管痉挛可能导致这种现象。